Medical cannabis cultivator Glass Pharms has officially delivered its first crop to the first UK-based clinic, marking the first time since medical cannabis was legalised that domestically grown product has been made available to patients.
The launch of UK-grown medical cannabis marks a significant milestone in the development of the market, which has long been hamstrung by its reliance on imported products and its impact on supply chains.
One of the first clinics set to begin distributing the first ‘Made in Britain’ stamped medical cannabis is Releaf, though Glass Pharms is understood to be sending its product to a number of UK customers.
“Our partnership with Glass Pharms represents a new era in medical cannabis for the UK,” said Tim Kirby, Managing Director of Releaf.
“By offering locally grown, sustainable cannabis medication, we are not only meeting a significant unmet need in the healthcare industry and improving patient access, but also reducing our environmental impact and supporting domestic industry.”
Domestic Supply
Through its strategic partnership with Glass Pharms, Releaf will now offer a range of its own-branded medical cannabis flower products through its platform.
Glass Pharms has long made its ambition to supply the domestic market clear, telling Business of Cannabis earlier this year that the UK was its initial target market, specifically ‘solving for out-of-stock issues’ for UK patients.
“We believe that if that supply chain is replaced, and patients have the experience of being able to receive a reliable, repeatable, standardised medicine that works, that removes one of the key pieces of friction from the industry itself,” it said.
To achieve this, Glass Pharms says it has developed a ‘continuous production model’, which will harvest ‘every week of the year’, significantly shortening the supply chain and allowing the company to provide fresh flowers with ‘exacting standards’ of terpene and cannabinoid profiles.
Mr Kirby told Business of Cannabis: “I didn’t realise, as we embarked on this journey in February, just how broken the supply chain was. These closed-loop ecosystems just don’t support any business at scale.
“It was kind of this serendipitous moment. We refunded £40,000 last month to patients because we didn’t meet our charter in terms of timely delivery. We said we’d deliver within seven days, but that didn’t happen.
“And then exactly the same time I met James and Mark at Glass Pharms, and they had a similar view to me as to the root cause of the stagnation of the UK, and they were just literally about to have their first harvest.”
He continued that Releaf agreed to buy ‘as much of their first production as possible’, and found a partner to handle the store, finish and package Glass Pharms’ product into Releaf-branded medical cannabis flower.
“Not only have we sort of secured the ecosystem in terms of supply, but we have flattened the supply chain in terms of how you get it in front of the patient.”
The pair have reportedly agreed to a 12-month contract, which will see Glass Pharms utilise its continuous growth cycle to effectively cultivate to Releaf’s forecast ‘for 16 weeks out’.
Glass Pharms CEO, James Duckenfield, added: “Patients will now have a security of supply that was previously missing from a market that previously relied on imports. The ability for clinicians to write repeat prescriptions of the same product was previously hit and miss due to supply chain problems. Our continuous harvesting model will help bring an end of the out-of-stock issues that have set back the development of this promising therapeutic area in the UK.
“We are happy that Releaf is our first customer to bring our flower to market. They have a strong focus on patient experience with an excellent proprietary technology platform to enable it. The combined offering is great news for patients, particularly those who care about the environment.”
UK Supply Chain
As noted in Prohibition Partners’ European Cannabis Report: 9th Edition, the UK’s medical cannabis market is now the second largest in Europe, and is the core driver of growth in the region.
Despite this growth, and unusually high consumption from UK patients, its supply chain and importation hurdles continue to restrain its potential.
Source: Prohibition Partners’ European Cannabis Report: 9th Edition
The importation process for finished medical cannabis products is also costly and highly bureaucratic. Products can only be imported on the basis of letters of ‘clinical need’ from doctors, which detail the specific product requirements (i.e. specific quantities of specific named products), and only for a period of three months.
This process results in higher costs to patients for products, and lower consistency and availability of the product supply.
To meet the growing demand, clinics have worked around these issues by importing intermediate products instead of finished products, opting to perform the final manufacturing steps within the UK.
This allows them to import medical cannabis classified as a Schedule I Raw Material, which is cheaper and easier to bring into the country than a Schedule II Finished Product.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duration
Description
__cfduid
1 month
The cookie is used by cdn services like CloudFare to identify individual clients behind a shared IP address and apply security settings on a per-client basis. It does not correspond to any user ID in the web application and does not store any personally identifiable information.
__hssrc
session
This cookie is set by Hubspot. According to their documentation, whenever HubSpot changes the session cookie, this cookie is also set to determine if the visitor has restarted their browser. If this cookie does not exist when HubSpot manages cookies, it is considered a new session.
cookielawinfo-checbox-analytics
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional
11 months
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-advertisement
1 year
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertisement".
cookielawinfo-checkbox-necessary
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy
11 months
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Cookie
Duration
Description
__hssc
30 minutes
This cookie is set by HubSpot. The purpose of the cookie is to keep track of sessions. This is used to determine if HubSpot should increment the session number and timestamps in the __hstc cookie. It contains the domain, viewCount (increments each pageView in a session), and session start timestamp.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Cookie
Duration
Description
_gat
1 minute
This cookies is installed by Google Universal Analytics to throttle the request rate to limit the colllection of data on high traffic sites.
ac_enable_tracking
1 month
This cookie is set by the Active Campaign. This cookie is used to keep track of the site usage.
YSC
session
This cookies is set by Youtube and is used to track the views of embedded videos.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Cookie
Duration
Description
__hstc
1 year 24 days
This cookie is set by Hubspot and is used for tracking visitors. It contains the domain, utk, initial timestamp (first visit), last timestamp (last visit), current timestamp (this visit), and session number (increments for each subsequent session).
_ga
2 years
This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors.
_gid
1 day
This cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visted in an anonymous form.
hubspotutk
1 year 24 days
This cookie is used by HubSpot to keep track of the visitors to the website. This cookie is passed to Hubspot on form submission and used when deduplicating contacts.
iutk
5 months 27 days
This cookie is used by Issuu analytic system. The cookies is used to gather information regarding visitor activity on Issuu products.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Cookie
Duration
Description
IDE
1 year 24 days
Used by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
mc
1 year 1 month
This cookie is associated with Quantserve to track anonymously how a user interact with the website.
test_cookie
15 minutes
This cookie is set by doubleclick.net. The purpose of the cookie is to determine if the user's browser supports cookies.
VISITOR_INFO1_LIVE
5 months 27 days
This cookie is set by Youtube. Used to track the information of the embedded YouTube videos on a website.
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
Cookie
Duration
Description
__smSessionId
9 hours
No description
__smVID
1 month
This cookie is set by Sumo. The purpose of the cookie is not yet known.
CONSENT
16 years 8 months 13 days 11 hours
No description
lfuuid
9 years 9 months 13 days 11 hours
Third party (Lead Forensics) cookie which enables us to track visitor behaviour on our site. Tracking is performed anonymously until a user identifies themselves by submitting a form.